Shenol A, Tenente R, Luckmann M, Frimurer T, Schwartz T
Nat Commun. 2024; 15(1):5364.
PMID: 38918366
PMC: 11199501.
DOI: 10.1038/s41467-024-49536-y.
Luckmann M, Trauelsen M, Bentsen M, Nissen T, Martins J, Fallah Z
Proc Natl Acad Sci U S A. 2019; 116(14):7123-7128.
PMID: 30872479
PMC: 6452680.
DOI: 10.1073/pnas.1811066116.
Soldner C, Horn A, Sticht H
J Mol Model. 2018; 24(12):346.
PMID: 30498974
DOI: 10.1007/s00894-018-3873-7.
Ntumngia F, Thomson-Luque R, Pires C, Adams J
J Receptor Ligand Channel Res. 2017; 9:1-11.
PMID: 28943755
PMC: 5608092.
DOI: 10.2147/JRLCR.S99725.
Hauge M, Vestmar M, Husted A, Ekberg J, Wright M, Di Salvo J
Mol Metab. 2015; 4(1):3-14.
PMID: 25685685
PMC: 4314522.
DOI: 10.1016/j.molmet.2014.10.002.
Identification and functional comparison of seven-transmembrane G-protein-coupled BILF1 receptors in recently discovered nonhuman primate lymphocryptoviruses.
Spiess K, Fares S, Sparre-Ulrich A, Hilgenberg E, Jarvis M, Ehlers B
J Virol. 2014; 89(4):2253-67.
PMID: 25505061
PMC: 4338891.
DOI: 10.1128/JVI.02716-14.
Assessment and challenges of ligand docking into comparative models of G-protein coupled receptors.
Nguyen E, Norn C, Frimurer T, Meiler J
PLoS One. 2013; 8(7):e67302.
PMID: 23844000
PMC: 3699586.
DOI: 10.1371/journal.pone.0067302.
Structure of the human smoothened receptor bound to an antitumour agent.
Wang C, Wu H, Katritch V, Han G, Huang X, Liu W
Nature. 2013; 497(7449):338-43.
PMID: 23636324
PMC: 3657389.
DOI: 10.1038/nature12167.
The essential role for aromatic cluster in the β3 adrenergic receptor.
Cai H, Xu Z, Tang J, Sun Y, Chen K, Wang H
Acta Pharmacol Sin. 2012; 33(8):1062-8.
PMID: 22728712
PMC: 4011317.
DOI: 10.1038/aps.2012.55.
Molecular requirements for inhibition of the chemokine receptor CCR8--probe-dependent allosteric interactions.
Rummel P, Arfelt K, Baumann L, Jenkins T, Thiele S, Luttichau H
Br J Pharmacol. 2012; 167(6):1206-17.
PMID: 22708643
PMC: 3504988.
DOI: 10.1111/j.1476-5381.2012.02076.x.
Reversed binding of a small molecule ligand in homologous chemokine receptors - differential role of extracellular loop 2.
Jensen P, Thiele S, Steen A, Elder A, Kolbeck R, Ghosh S
Br J Pharmacol. 2011; 166(1):258-75.
PMID: 22050085
PMC: 3415653.
DOI: 10.1111/j.1476-5381.2011.01771.x.
Allosteric and orthosteric sites in CC chemokine receptor (CCR5), a chimeric receptor approach.
Thiele S, Steen A, Jensen P, Mokrosinski J, Frimurer T, Rosenkilde M
J Biol Chem. 2011; 286(43):37543-54.
PMID: 21878623
PMC: 3199500.
DOI: 10.1074/jbc.M111.243808.
A conserved aromatic lock for the tryptophan rotameric switch in TM-VI of seven-transmembrane receptors.
Holst B, Nygaard R, Valentin-Hansen L, Bach A, Engelstoft M, Petersen P
J Biol Chem. 2009; 285(6):3973-3985.
PMID: 19920139
PMC: 2823539.
DOI: 10.1074/jbc.M109.064725.
Probing the role of the cation-pi interaction in the binding sites of GPCRs using unnatural amino acids.
Torrice M, Bower K, Lester H, Dougherty D
Proc Natl Acad Sci U S A. 2009; 106(29):11919-24.
PMID: 19581583
PMC: 2715518.
DOI: 10.1073/pnas.0903260106.
An overview on GPCRs and drug discovery: structure-based drug design and structural biology on GPCRs.
Lundstrom K
Methods Mol Biol. 2009; 552:51-66.
PMID: 19513641
PMC: 7122359.
DOI: 10.1007/978-1-60327-317-6_4.
Chemokine receptor antagonists: overcoming developmental hurdles.
Horuk R
Nat Rev Drug Discov. 2008; 8(1):23-33.
PMID: 19079127
DOI: 10.1038/nrd2734.
Designing human m1 muscarinic receptor-targeted hydrophobic eigenmode matched peptides as functional modulators.
Selz K, Mandell A, Shlesinger M, Arcuragi V, Owens M
Biophys J. 2004; 86(3):1308-31.
PMID: 14990463
PMC: 1303971.
DOI: 10.1016/S0006-3495(04)74204-6.
Somatostatin and somatostatin receptor physiology.
Barnett P
Endocrine. 2003; 20(3):255-64.
PMID: 12721505
DOI: 10.1385/ENDO:20:3:255.
Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain.
Boucard A, Sauve S, Guillemette G, Escher E, Leduc R
Biochem J. 2002; 370(Pt 3):829-38.
PMID: 12495432
PMC: 1223243.
DOI: 10.1042/BJ20021566.
Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
Gigoux V, Maigret B, Escrieut C, Silvente-Poirot S, Bouisson M, Fehrentz J
Protein Sci. 1999; 8(11):2347-54.
PMID: 10595537
PMC: 2144185.
DOI: 10.1110/ps.8.11.2347.
